SCHEMBL6072249

SCHEMBL6072249

CCNC(=O)c1cc(Oc2ccc3c(c2)CCN3C(=O)O)ccn1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.48
RAF1 P04049 5/20 0.47
BRAF P15056 1/20 0.47
FGFR1 P11362 1/20 0.46
MET P08581 2/20 0.45
TP53 P04637 2/20 0.42
POLB P06746 1/20 0.42
NOTUM Q6P988 1/20 0.42
KDR P35968 2/20 0.42
MAPK14 Q16539 2/20 0.42
THRB P10828 1/20 0.41
LMNA P02545 1/20 0.40
RIPK1 Q13546 1/20 0.40
NFKB1 P19838 1/20 0.40
NR2C2 P49116 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TAB1 Q15750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072145 0.92 MET (0.47) HRH3RAF1BRAFFGFR1MET
SCHEMBL6072612 0.92 NOTUM (0.53) HRH3RAF1BRAFFGFR1MET
SCHEMBL6072190 0.89 HTT (0.46) RAF1BRAFFGFR1METTP53
SCHEMBL6072492 0.89 ADRB2 (0.47) HRH3FGFR1METTP53POLB
SCHEMBL6071927 0.89 KDR (0.52) HRH3RAF1BRAFKDRMAPK14
SCHEMBL6072403 0.87 FGFR1 (0.39) HRH3RAF1BRAFFGFR1MET
SCHEMBL6071686 0.87 LMNA (0.48) HRH3FGFR1METTP53POLB
SCHEMBL6072151 0.87 RAF1 (0.44) HRH3RAF1BRAFFGFR1NOTUM
SCHEMBL6072244 0.85 RIPK1 (0.43) METTP53POLBLMNARIPK1
SCHEMBL6072351 0.85 SMN1; SMN2 (0.47) TP53POLBLMNARIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241149-A1 Chemical compounds ADAMS JERRY L 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241149-A1 Chemical compounds CHKB, MAP3K20, MAP3K6 HRH3 854/4885RAF1 205/4885BRAF 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.